Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

38.50 -0.11 (-0.28%)
Streaming Delayed Price Updated: 3:09 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 285,528
Open 38.13
Bid (Size) 38.43 (300)
Ask (Size) 38.50 (500)
Prev. Close 38.61
Today's Range 37.60 - 38.52
52wk Range 22.66 - 55.00
Shares Outstanding 43,474,327
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call
Omnicell’s fourth quarter was met with a significant negative market reaction, as the company delivered revenue in line with Wall Street expectations but posted a notable shortfall in non-GAAP... 
Via StockStory
Topics Earnings
News headline image
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook
Healthcare tech company Omnicell (NASDAQ:OMCL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 2.3% year on year to $314 million. The company expects next quarter’s revenue to be... 
Via StockStory
Topics World Trade

Performance

YTD
-14.7%
-14.7%
1 Month
-21.5%
-21.5%
3 Month
+11.5%
+11.5%
6 Month
+21.3%
+21.3%
1 Year
-3.7%
-3.7%

More News

Read More
News headline image
Why Omnicell (OMCL) Shares Are Plunging Today
Via StockStory
Topics Artificial Intelligence
Omnicell Inc (NASDAQ:OMCL) Stock Plummets on Earnings Miss and Soft 2026 Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Omnicell (OMCL) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Via StockStory
News headline image
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Earnings: What To Look For From OMCL
Via StockStory
Topics Artificial Intelligence
News headline image
Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)
Via StockStory
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
Via StockStory
Topics Stocks
News headline image
3 Russell 2000 Stocks We Approach with Caution
Via StockStory
News headline image
3 Reasons to Sell OMCL and 1 Stock to Buy Instead
Via StockStory
News headline image
3 Small-Cap Stocks We Keep Off Our Radar
Via StockStory
News headline image
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
From Omnicell, Inc.
Via Business Wire
News headline image
3 Inflated Stocks with Open Questions
Via StockStory
News headline image
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
Via StockStory
News headline image
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management
From Omnicell, Inc.
Via Business Wire
News headline image
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off
Via StockStory
Topics Stocks
News headline image
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show
From Omnicell, Inc.
Via Business Wire
News headline image
Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz
Via StockStory
News headline image
3 Low-Volatility Stocks That Concern Us
Via StockStory
News headline image
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies
From Omnicell, Inc.
Via Business Wire

Frequently Asked Questions

Is Omnicell, Inc. - Common Stock publicly traded?
Yes, Omnicell, Inc. - Common Stock is publicly traded.
What exchange does Omnicell, Inc. - Common Stock trade on?
Omnicell, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Omnicell, Inc. - Common Stock?
The ticker symbol for Omnicell, Inc. - Common Stock is OMCL on the Nasdaq Stock Market
What is the current price of Omnicell, Inc. - Common Stock?
The current price of Omnicell, Inc. - Common Stock is 38.50
When was Omnicell, Inc. - Common Stock last traded?
The last trade of Omnicell, Inc. - Common Stock was at 02/19/26 03:09 PM ET
What is the market capitalization of Omnicell, Inc. - Common Stock?
The market capitalization of Omnicell, Inc. - Common Stock is 1.67B
How many shares of Omnicell, Inc. - Common Stock are outstanding?
Omnicell, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.